Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AV9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,638
Award facts
- Contract value 100% obligated
- $25,637.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,637.70 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on January 28, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 19, 2026, performed at the awardee's facility in Conshohocken, Pennsylvania. Ocrevus is a specialty pharmaceutical treatment for multiple sclerosis, reflecting the critical role that AmerisourceBergen plays in supplying specialized medications to support military healthcare systems and other federal medical institutions.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031. That prime contract vehicle enables comprehensive global pharmaceutical support across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines to serve the Defense Health Agency and other federal healthcare systems. The competitively awarded nature of this delivery order, combined with Cencora's established capacity as a primary pharmaceutical vendor, demonstrates the company's continued capability to fulfill critical medical supply requirements for military treatment facilities and federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F1AV9?
SPE2DR26F1AV9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F1AV9 worth?
The government has obligated $25,638 on SPE2DR26F1AV9.
Is contract SPE2DR26F1AV9 an order under another contract?
Yes. SPE2DR26F1AV9 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AV9 competed?
The extent of competition for SPE2DR26F1AV9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award